These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 18448139)
1. Cholesterol esterification reduces the neurotoxicity of prions. Bate C; Tayebi M; Williams A Neuropharmacology; 2008 Jun; 54(8):1247-53. PubMed ID: 18448139 [TBL] [Abstract][Full Text] [Related]
2. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation. Bate C; Tayebi M; Williams A BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734 [TBL] [Abstract][Full Text] [Related]
3. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis. Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454 [TBL] [Abstract][Full Text] [Related]
4. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. Bate C; Salmona M; Diomede L; Williams A J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889 [TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells. Bate C; Tayebi M; Diomede L; Salmona M; Williams A BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130 [TBL] [Abstract][Full Text] [Related]
6. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. Bate C; Reid S; Williams A J Biol Chem; 2004 Aug; 279(35):36405-11. PubMed ID: 15210691 [TBL] [Abstract][Full Text] [Related]
7. And then there were acyl coenzyme A:cholesterol acyl transferase inhibitors. Meuwese MC; Franssen R; Stroes ES; Kastelein JJ Curr Opin Lipidol; 2006 Aug; 17(4):426-30. PubMed ID: 16832167 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic? López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422 [TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880 [TBL] [Abstract][Full Text] [Related]
10. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046 [TBL] [Abstract][Full Text] [Related]
11. Bavachin and isobavachalcone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia. Choi JH; Rho MC; Lee SW; Choi JN; Kim K; Song GY; Kim YK Arch Pharm Res; 2008 Nov; 31(11):1419-23. PubMed ID: 19023538 [TBL] [Abstract][Full Text] [Related]
12. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation. Bate C; Tayebi M; Williams A J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265 [TBL] [Abstract][Full Text] [Related]
13. The ACAT inhibitor VULM1457 significantly reduced production and secretion of adrenomedullin (AM) and down-regulated AM receptors on human hepatoblastic cells. Drímal J; Fáberová V; Schmidtová L; Bednáriková M; Drímal J; Drímal D Gen Physiol Biophys; 2005 Dec; 24(4):397-409. PubMed ID: 16474185 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine (YIC-C8-434), an acyl-CoA:cholesterol O-acyltransferase inhibitor, on cholesterol esterification in the intestine and liver. Ohishi K; Sawada H; Yoshida Y; Yokoi W; Hatano H; Aiyama R; Watanabe T; Yokokura T Biol Pharm Bull; 2003 Aug; 26(8):1125-8. PubMed ID: 12913263 [TBL] [Abstract][Full Text] [Related]
15. Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis. Tayebi M; David M; Bate C; Jones D; Taylor W; Morton R; Pollard J; Hawke S J Gen Virol; 2010 Dec; 91(Pt 12):3105-15. PubMed ID: 20797970 [TBL] [Abstract][Full Text] [Related]
16. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2. Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816 [TBL] [Abstract][Full Text] [Related]
17. Role of glycosylphosphatidylinositols in the activation of phospholipase A2 and the neurotoxicity of prions. Bate C; Williams A J Gen Virol; 2004 Dec; 85(Pt 12):3797-3804. PubMed ID: 15557253 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of phospholipase A2 increased the removal of the prion derived peptide PrP82-146 from cultured neurons. Bate C; Ingham V; Williams A Neuropharmacology; 2011; 60(2-3):365-72. PubMed ID: 20934441 [TBL] [Abstract][Full Text] [Related]
19. Sex-dependent toxicity of a novel acyl-CoA:cholesterol acyltransferase inhibitor, YIC-C8-434, in relation to sex-specific forms of cytochrome P450 in rats. Kaneko K; Uchida K; Kobayashi T; Miura K; Tanokura K; Hoshino K; Kato I; Onoue M; Yokokura T Toxicol Sci; 2001 Dec; 64(2):259-68. PubMed ID: 11719709 [TBL] [Abstract][Full Text] [Related]